VNtyper 2 enables open-access short-read genotyping of MUC1 VNTR variants in ADTKD at high-speed
Popp, B.; Saei, H.; Teltsh, O.; Janousek, V.; Pristoupilova, A.; Vrbacka, A.; Hartmannova, H.; Kidd, K.; Helmuth, J.; Bleyer, A. J.; Wiesener, M.; Fausch, K.; Rowan, C.; Hassan, E. E.; Clince, M.; Cavalleri, G.; Locher, M.; Eckardt, K.-U.; Richter-Pechanska, P.; ADTKD-Net Consortium, ; Kmoch, S.; Antignac, C.; Conlon, P.; Dorval, G.; Zivna, M.; Halbritter, J.
Show abstract
Background: ADTKD-MUC1 is one of the major entities of ADTKD caused by frameshift variants in the MUC1 VNTR that standard short-read sequencing fails to detect. Existing 59dupC-targeted probe-extension assays do not allow for broad screening and cannot detect atypical non-dupC variants. Recently, VNtyper, a Kestrel-based genotyping pipeline with optional code-adVNTR cross-validation for MUC1 VNTR genotyping from short-read sequencing data allowed to circumvent this diagnostic limitation, but needed further development for easy access and rapid sample processing. Methods: We developed VNtyper 2, by refactoring VNtyper into a modular, production-grade tool with a companion web platform, VNtyper-Online (https://vntyper.org), for freely available browser-based analysis with short turnaround time and without local bioinformatics infrastructure. We validated VNtyper 2 on 400 simulated samples generated with MucOneUp and 142 clinical exomes with independently confirmed genotypes. Results: In simulation, VNtyper 2 detected the canonical 59dupC variant with 96% sensitivity and 100% specificity. Reference-standard validation on 142 samples yielded 90.6% sensitivity and 98.2% specificity overall, with cohort-dependent performance across the Twist Exome v2 French-German cohort (98% sensitivity, 87.5% specificity) and the KAPA HyperExome V2 (Roche) Czech-US cohort (79.4% sensitivity, 100% specificity). Screening of 3582 exomes and targeted panels from international CKD referral programmes identified 51 positive individuals, including 9 with atypical non-dupC frameshift variants that would have been missed by 59dupC-targeted probe-extension assays. In unselected CKD cohorts, a descriptive random-effects summary estimated a detection rate of 1.4% (95% CI 0.6 to 3.1%). Conclusions: VNtyper 2 and VNtyper-Online are open-source tools for MUC1 VNTR genotyping from short-read data and can support locally validated workflows when VNTR coverage is adequate. By improving accessibility and turnaround time, these tools democratize MUC1 diagnostics at global scale. For its integration into routine diagnostics, we propose an expert-informed two-pathway workflow developed through European ADTKD-Net consortium consensus.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Phenotypic spectrum of FAM47E - SHROOM3 haplotype composition in a general population sample 92%
- ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysis 92%
- Urine single cell RNA-sequencing in focal segmental glomerulosclerosis reveals inflammatory signatures in immune cells and podocytes 90%
Similar papers in this journal
- Nanopore sequencing with unique molecular identifiers enables accurate mutation analysis and haplotyping in the complex Lipoprotein(a) KIV-2 VNTR 94%
- Evaluating Genome Sequencing Strategies: Trio, Singleton, and Standard Testing in Rare Disease Diagnosis 93%
- Genome-Wide Sequencing as a First-Tier Screening Test for Short Tandem Repeat Expansions 92%
Similar papers in this journal
- Genetic Risk Factors for Severe and Fatigue Dominant Long COVID and Commonalities with ME/CFS Identified by Combinatorial Analysis 90%
- Tissue of origin detection for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks 88%
- Genomic Insights Guiding Personalized First-Line Immunotherapy Response in Lung and Bladder Tumors 87%
Similar papers in this journal
- The Interpretable Multimodal Machine Learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy 90%
- Leveraging sequences missing from the human genome to diagnose cancer 90%
- A user-friendly tool for cloud-based whole slide image segmentation, with examples from renal histopathology 90%
Similar papers in this journal
- Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes 90%
- Spatial proteomics of human diabetic kidney disease, from health to class III 90%
- High-throughput Genetic Clustering of Type 2 Diabetes Loci Reveals Heterogeneous Mechanistic Pathways of Metabolic Disease 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.